Medical Cannabis

Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.

The Texas Department of Public Safety has announced a list of nine businesses that will move forward in Phase I of the Texas Compassionate Use Program.

In honor of Green Wednesday on November 26, 2025, we are excited to share with you our Green Wednesday-themed round up of medical cannabis research.

Check out our exciting 2025 Green Wednesday coverage!

The Senate’s reopening the government bill has passed but it includes a section that redefines hemp and can ban hemp products with a greater amount of 0.4 mg total THC.

A study looked into the beneficial role THC-CBD cannabis extracts may play with Alzheimer’s disease-associated dementia.

Our top cannabis news topics this week: new training programs, lawsuits, state enforcement, and clinical research findings.

A new study finds that THC:CBD cannabis oil may improve appetite and quality of life in systemic sclerosis patients.

Recently, the Virginia Cannabis Control Authority established a training program for practitioners through a partnership with TheAnswerPage.com.

The new study found that education intervention resulted in improvements in patient symptom management.

Our top five cannabis and hemp news this week: Ohio hemp regulation, NY dispensary laws, updates from Florida, and medical cannabis research.

Dr. Dustin Sulak reviews studies on medical cannabis in this month’s webinar, including research on Tourette syndrome, chemotherapy-induced neuropathy, and caregiver wellbeing.

According to a recent study, plant-derived cannabis extracts containing THC, CBD, and CBG, may offer superior short-term and long-term pain relief than opioids for chronic lower back pain patients.

What role does cannabis play in sleep quality and health-related conditions?

Our top five cannabis and hemp news this week: cannabis sales milestones in Minnesota and Virginia, new CBD research, and Colorado’s latest regulatory updates.

The Virginia Cannabis Control Authority reported data on medical cannabis sales and most popular products for July to August 2025.

Our top five cannabis and hemp news this week: OCM fines NY lab, Congress halts rescheduling funding, Texas issues hemp order, NJ supports businesses with $15M in funding, and our latest podcast episode.

A UK Medical Cannabis Registry study found cannabis-based medicines improved sleep, anxiety, and quality of life in insomnia patients.

According to the Division of Cannabis Control, medical marijuana sales exceeded $2.2 billion and recreational cannabis generated over $785 million since legalization.

The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.

Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

Here, we bring you our top four recent articles covering research on cannabinoids and sleep, why enrolled patients turn to illegal cannabis, using spent hemp biomass as livestock feed, and testing cannabinoids on breath after ingesting edibles.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.